baber/WOPTO huggingface dataset:
Patent NZ-540511-A (NZ)
Title: Dispenser having a conduit with a flow restrictor
Inventor: WAUTERS ALBERT
IPC: B67D1/14
Filed: 2003-11-26
Abstract: The present invention relates to a conduit for conducting gasified liquid, which has a flow restrictor arranged in in-line relation therewith. The restrictor itself comprises an at least one aperture (although two or more can be used in series), with each such being adapted to pass the gasified liquid flowing through the conduit and across a pressure drop from a higher-pressure upstream side of the aperture to a lower-pressure downstream side of the aperture. The aperture is operable to moderate the rate of change in pressure over a transitional pressure drop to mitigate the formation of localized pressures below a critical pressure at which off-gassing from the carbonated liquid results in substantial foam formation. The conduit may take the form of a dispensing tube for use in dispensing an alcoholic beverage from a keg, the tube having a flexible wall deformable under the influence of a restricting actuator to control the partial collapse of the wall and thereby form the restrictor. The tube or flow diameter downstream of the restrictor only gradually or slowly increases.
Patent NZ-540548-A (NZ)
Title: Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
Inventor: ELZEIN ELFATIH
IPC: C07D417/12
Filed: 2003-12-05
Abstract: Substituted piperazine compounds and their use as fatty acid oxidation inhibitors is disclosed, wherein these compounds are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
Patent NZ-543557-A (NZ)
Title: A method for the preparation of a polypeptide of interest by enzymatic cleavage of fusion proteins using Granzyme B protease
Inventor: LORENTSEN RIKKE HOEGH
IPC: C12N9/64
Filed: 2004-04-23
Abstract: Disclosed is a method for the preparation of a polypeptide of interest in authentic form by enzymatic cleavage of fusion proteins using Granzyme B protease. There is also provided fusion proteins comprising a polypeptide of interest and a fusion partner, wherein the junction region between the polypeptide of interest and the fusion partner comprises a Granzyme B protease cleavage site adjacent to the polypeptide of interest.
Patent NZ-549654-A (NZ)
Title: A method of online payment authorization, a method of correlating text messages and systems therefor
Inventor: LAMBERT MELANIE JOY
IPC: G06Q30/00
Filed: 2006-09-01
Abstract: A method of correlating text messages by allocating a sending address to an outgoing text message, sending the outgoing text message to a recipient address from the sending address, receiving an incoming text message from the recipient address to the sending address and correlating the outgoing and incoming text messages based on the sending address and recipient address. The method may be used to automatically action payment or other instructions or to actuate a physical actuator. The sending address may be selected from a pool of codes, such as short codes.
Patent NZ-551728-A (NZ)
Title: Factor VIIa inhibitor
Inventor: DICKMAN DANIEL A
IPC: C07D235/00
Filed: 2005-06-02
Abstract: Disclosed are compounds of formulas I, I (b) and I (c) wherein the substituents are as defined in the specification. Also disclosed are the processes for preparing these compounds. The said compounds are Factor VIIa inhibitors and are useful for treatment and/or prevention of thromboembolic disorders, cancer or rheumatoid arthritis.
Patent NZ-556686-A (NZ)
Title: Novel tubulin polymerisation inhibitors
Inventor: CHAPLIN JASON HUGH
IPC: A61K31/343
Filed: 2006-02-14
Abstract: The present disclosure relates to as tublin polymerisation inhibitors of general formula (I), wherein the substituents are defined in the specification. Also disclosed are methods for preparing such compounds and the use of such compounds in the preparation of medicaments for the treatment of cancer and inflammation.
Patent NZ-568464-A (NZ)
Title: Materials and methods for treating viral infections with a cysteamine compound
Inventor: LIANG HAO YI
IPC: A61K31/145
Filed: 2006-11-28
Abstract: Provided is the use of cysteamine or a salt thereof in the preparation of a medicament for administering to a subject diagnosed with an influenza viral infection (including avian influenza virus subtypes) so as to treat or prevent said influenza viral infection, associated symptoms or associated complications.
Patent NZ-578569-A (NZ)
Title: Medicament for the treatment of endometriosis using dopamine agonists cabergoline or quinagolide
Inventor: PELLICER-MARTINEZ ANTONIO
IPC: A61P15/00
Filed: 2008-02-01
Abstract: Disclosed is the use of a dopamine agonist comprising cabergoline or quinagolide in the manufacture of a medicament for the treatment or prevention of endometriosis.
Patent NZ-579755-A (NZ)
Title: Peptide mixture as wine stabiliser
Inventor: LANKHORST PETER PHILIP
IPC: C12P21/06
Filed: 2008-04-17
Abstract: Disclosed is a composition, when used for the stabilisation of wine against crystallisation of salts of tartaric acid, comprising at least 2.5% of a peptide mixture based on dry weight of the composition, wherein the peptides in the peptide mixture have a molecular weight ?3 kDa and ?10 kDa and that the peptides are from yeast. Also disclosed is a process to stabilize wine by preventing and/or retarding the crystallization of salts of tartaric acid wherein a composition comprising at least 2.5% of a peptide mixture based on dry weight of the composition wherein the peptides in the peptide mixture have a molecular weight ?3 kDa and ?10 kDa is added to wine or to grape must to be used in the production of wine.
Patent NZ-580892-A (NZ)
Title: Foundation using a central member with a keyway or projection mating with a plurality of foundation segments
Inventor: ARMBRECHT ACHIM
IPC: E02D27/32
Filed: 2009-11-02
Abstract: A foundation (1) for a wind turbine is disclosed. The foundation (10 is constructed from two types of precast parts. The first is a central foundation member (7) and the second is a foundation segment (2). A plurality of segments (2) surround the central foundation member (7) and form a circular, ring shaped or polygonal foundation element. The segments (2) are connected to the central foundation member (7) by means of one or more locking elements. The locking elements are a ring shaped or polygonal projection (8) from the central foundation member (7) which couples to a ring shaped or polygonal recess (12) in each segment (2). Conversely the recess may be in the central foundation member (7) and the projection on each segment (2). A tower is constructed on top of the foundation using fastening means (4) to connect it to the foundation (1).
Patent NZ-581703-A (NZ)
Title: Multigene prognostic assay for lung cancer
Inventor: RAZ DAN J
IPC: C12Q1/68
Filed: 2008-05-30
Abstract: Provided is a method of providing a prognosis for lung cancer in a subject, the method comprising the steps of: (a) contacting a biological sample from the subject with eight different reagents that each specifically binds to a different nucleic acid comprising one of ctnnb 1, wnt3a, tp53, kras, erbb3, muc1, erbb2, and dusp6, and (b) determining whether or not all of the eight nucleic acids are differentially expressed in the sample in comparison to a non-cancer cell; thereby providing a prognosis for lung cancer. The markers can be quantified using PCR amplification with oligonucleotide probes.
Patent NZ-587665-A (NZ)
Title: Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
Inventor: PARR RYAN
IPC: C12N15/12
Filed: 2006-04-18
Abstract: Provided is a method of detecting a deletion spanning approximately nucleotides 547 to 4443 in the minor arc of the human mtDNA genome, wherein said deletion is associated with skin cancer and/or UV exposure, comprising: (a) providing a biological sample; (b) extracting mtDNA from the biological sample; and (c) detecting the presence of the deletion in the mtDNA. Further provided are microarray kits comprising the sequence of the deletion.
Patent NZ-588358-A (NZ)
Title: Two way pressure relief valve with a primary valve and at least one vacuum valve.
Inventor: DUNCAN GARY JAMES
IPC: F16K17/196
Filed: 2011-12-16
Abstract: A pressure relief valve adapted to be mounted over an aperture in a container including a housing (3), a valve seat, and a valve assembly (8) which includes a primary valve (17) and at least one vacuum valve (35). The primary valve (17) includes a primary valve piston which is mounted for reciprocation within the housing (3) upon a ram shaft (9) which carries a ram piston (42). The said ram piston (42) is reciprocally mounted within a chamber (50) which can be pressurised. The primary valve piston is dimensioned and arranged such that said primary valve (17) is closed only when the primary valve piston contacts the valve seat. The primary valve piston is arranged to close when the air pressure in the pressurised chamber (50) exceeds a first predetermined value and to open when the pressure in the container exceeds a second predetermined value and the or each vacuum valve (35) is arranged to open when the pressure in the container is less than a third predetermined value.
Patent NZ-589909-A (NZ)
Title: Piperidinyl derivative as a modulator of chemokine receptor activity
Inventor: SANTELLA JOSEPH B
IPC: A61K31/451
Filed: 2009-06-25
Abstract: Disclosed are compounds of formula (I), pharmaceutically acceptable salt forms thereof, and methods for their preparation. The compounds of formula (I) are used in the modulation of chemokine (chemotactic cytokines) or chemokine receptor activity such as CCR-1 or CCR-1 receptor activity. They can be used for treating a disorder selected from osteoarthritis, aneurysm, fever, cardiovascular effects, Crohn's disease, congestive heart failure, autoimmune diseases, HIV-infection, HIV-associated dementia, psoriasis, idiopathic pulmonary fibrosis, transplant arteriosclerosis, physically- or chemically-induced brain trauma, neuropathic pain, inflammatory bowel disease, alveolitis, ulcerative colitis, systemic lupus erythematosus, nephrotoxic serum nephritis, glomerulonephritis, asthma, multiple sclerosis, arthrosclerosis, rheumatoid arthritis, restenosis, organ transplantation, multiple myeloma, colorectal cancer, hepatocellular cancer and other cancers.
Patent NZ-591010-A (NZ)
Title: Process for preparing renin inhibitors such as aliskiren and derivatives thereof
Inventor: MICKEL STUART JOHN
IPC: C07D405/04
Filed: 2006-06-06
Abstract: Disclosed herein is a process for the manufacture of a compound of formula (IVa) wherein said process comprising removing a protecting groups R2 and PG in a compound of the formula (I), or a salt thereof and to form the pyrrolidine ring, wherein R is hydrogen, alkyl or alkoxyalkyl; R1 is hydrogen, alkyl or alkoxyalkyl; R2 is hydrogen or a hydroxyl protecting group; R3 is hydrogen or an alkyl; and PG is an amino protecting group. Also disclosed are processes for the manufacture of useful intermediate compounds for making compounds such as aliskiren, which are useful as renin inhibitors.
Patent NZ-595572-A (NZ)
Title: Inhibitors of pi3 kinase and / or mtor
Inventor: ANDREWS KRISTIN
IPC: A61K31/52
Filed: 2010-04-27
Abstract: NZ 595572 Disclosed are phosphoinositide 3-kinase (PI3K) inhibitor compounds of Formula I, as defined in the specification. The disclosed compounds are use in the treatment of cancer.
Patent NZ-596537-A (NZ)
Title: Density phase separation device
Inventor: BARTFELD BENJAMIN
IPC: B01D17/038
Filed: 2010-05-14
Abstract: A mechanical separator (40) for separating a fluid sample into first and second phases within a collection container (82) is disclosed. The mechanical separator (40) has a separator body with a through-hole (46) adapted for allowing fluid to pass through. The separator body includes a float (42), having a first density, and a ballast (44), having a second density greater than the first density. The body also includes a seal between the separator (40) and the container (82). In use the separator changes position in a centrifuge from a position in which fluid can flow (F) through the hole to a closed position.
Patent NZ-617885-A (NZ)
Title: A weighing device for an espresso coffee machine and an espresso coffee machine incorporating such a device
Inventor: MORAN SEAN MARTIN
IPC: G01G19/56
Filed: 2012-04-26
Abstract: A weighing device (11) is incorporated into an espresso coffee machine (10). The weighing device (11) is located in a drip tray (12) of the espresso coffee machine (10) under a group (13) thereof. The weighing device (11) has a display (not shown) for indicating the weight of a shot as it is being delivered and the elapsed time from the start of delivery. A start extraction button (not shown) on a pressure adjusting handle (24) mounted on the group (13) is connected to the weighing device (11). In use, movement of the pressure adjusting handle (24) initiates delivery of a shot from the group (13), which movement also activates the weighing device (11) in one mode of operation. Thus, a barista can use the weighing device to calibrate the “perfect shot” using the weight and time measurements displayed thereon.
Patent NZ-620652-A (NZ)
Title: New bicyclic dihydroquinoline-2-one derivatives
Inventor: MOHR PETER
IPC: C07D471/04
Filed: 2012-09-20
Abstract: The disclosure relates to bicyclic dihydroquinoline-2-one derivatives of general formula (I). The use of these compounds may be in the treatment of chronic kidney disease, congestive heart failure, hypertension, primary aldosteronism, Cushing syndrome, prophylaxis of diabetic nephropathy or prophylaxis of kidney or heart fibrosis. Example compounds include: (+)-N-[(7R,8R or 7S,8S)-4-(7-Fluoro-1-methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-7-methyl-5,6,7,8-tetrahydro-isoquinolin-8-yl]-propionamide; (+)-N-[(7S,8S or 7R,8R)-7-Fluoro-4-(1-methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-5,6,7,8-tetrahydro-isoquinolin-8-yl]-propionamide; (+)-(R or S)-N-(4-(8-Chloro-1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl)propionamide; 3-Chloro-pyridine-2-carboxylic acid [(R)-4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydro-isoquinolin-8-yl]-amide; N-[(R)-4-(1-Methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-5,6,7,8-tetrahydro-isoquinolin-8-yl]-acetamide; (+)-(R)-N-(4-(1-Methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide and (+)-(R)-N-(4-(1-Methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide.
Patent NZ-621386-A (NZ)
Title: Cyclopolysaccharide compositions
Inventor: CHEN YU
IPC: A61P35/00
Filed: 2012-09-14
Abstract: The present disclosure is directed to pharmaceutical compositions comprising: (a) a cyclopolysaccharide such as cyclodextrin and (b) a compound of Formula (I) or its pharmaceutical acceptable salt: wherein X1, X2 and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compositions. The compounds are derivatives of bendamustine.
Patent NZ-628051-A (NZ)
Title: Process for preparing infant formula
Inventor: VAN DEN BRENK JOEP
IPC: A23L33/00
Filed: 2013-03-13
Abstract: Disclosed is a process for preparing a spray-dried lipid and protein component-containing composition, which is a spray-dried infant or follow-on formula or growing up milk and comprises lipid globules, wherein a lipid and protein component-containing composition comprising lipid globules is spray-dried with an atomization system employing a two-fluid nozzle so as to obtain a spray-dried lipid and protein component-containing composition comprising lipid globules having a volume-weighted mode diameter of at least 1.0 μm.
Patent NZ-701357-A (NZ)
Title: Methods for modifying the solubility of a polymer in a solvent
Inventor: MEDOFF MARSHALL
IPC: H05B6/00
Filed: 2011-05-20
Abstract: The disclosure relates to a method of increasing the solubility of a polymer which is nonpolar or has low polarity, the method comprising: treating the polymer by irradiation with accelerated electrons to increase the solubility of the polymer after irradiation relative to the solubility of the polymer prior to the irradiation, wherein irradiating comprises exposing the polymer to an electron beam and applying to the polymer a total dose of radiation of at least 5 Mrads, wherein irradiating includes exposing the polymer to a particle beam comprising particles that are heavier than electrons, and wherein the molecular structure of the irradiated polymer is modified by disrupting the crystalline structure of the treated chemical, which increases the rate of dissolution of the chemical as well as increasing its solubility. Suitable polymers include natural and synthetic polymers which may be nonpolar polymers or polymers showing a low polarity, e.g., polyethylene, polystyrene, polybutadiene, poly(methyl methacrylate), poly(vinyl chloride), or poly(isobutylene), which are soluble in nonpolar solvents prior to physical treatment.
Patent NZ-716922-A (NZ)
Title: Roadside barrier post
Inventor: COLQUHOUN TERRY
IPC: E01F15/04
Filed: 2012-05-16
Abstract: A roadway, guard rail or safety barrier having a post and beam construction wherein the beam is mounted to the post by means of a carriage, the beam being secured to the carriage by a securement means, the carriage being adapted to travel longitudinally relative to the post in the event of a collision, the post further including at least one carriage support means, and one or more engagement means on an outer face of the post, the engagement means being adapted to be engaged by the securement means to provide resistance to movement of the carriage with respect to the post, wherein the carriage is sized and shaped so as to not engage or to minimise engagement with the engagement means during the movement. The engagement means can be formed bay a number of methods including deformation of the post.
Patent NZ-718411-A (NZ)
Title: Productivity enhancement for band saw
Inventor: BLENKINSOPP KEITH
IPC: B26D7/24
Filed: 2015-08-26
Abstract: Machine vision apparatus tracks a distinctive object in relation to a hazardous location on a work surface of a modified band saw in two, three, or four (3-D + T) dimensions, and calculates whether to send an “immediate shut-down signal” to the band saw. Cameras and image processing means are mounted on the band saw. The signal causes an integrated blade-arresting or stopping mechanism to immediately shift the idler wheel, removing blade tension and disconnecting the blade which is then braked to a complete, safe stop before an approaching blue-gloved hand can touch the blade.
Patent NZ-727087-A (NZ)
Title: Bioprocessing
Inventor: MEDOFF MARSHALL
IPC: C13K1/02
Filed: 2010-05-18
Abstract: Discloses a method of saccharifying a cellulosic or lignocellulosic material comprising contacting (i) a saccharifying agent that is immobilized on fibers or particles of an inorganic material with (ii) a cellulosic or lignocellulosic material to saccharify the cellulosic or lignocellulosic material, wherein the saccharifying agent is an enzyme or microorganism, wherein the inorganic material has been functionalized with carboxylic acid groups by irradiating the inorganic material with ionizing radiation and wherein the immobilization is due to interaction between functional groups on the fibers or particles and functional groups on the saccharifying agent.
Patent NZ-729518-A (NZ)
Title: Biomarkers and combination therapies using oncolytic virus and immunomodulation
Inventor: TUFARO FRANK
IPC: G01N33/574
Filed: 2013-01-25
Abstract: Disclosed is a method for predicting the response of a patient, with cancer or is suspected of having cancer, to an oncolytic virus comprising the steps of: (a) determining the level of expression of Th1 and/or Th2 biomarkers and/or antibodies against tumor associated antigens in a test sample; (b) comparing the levels of expression (in (a)) to a control, wherein the change in expression level relative to the control sample is predictive of the patient’s treatment response to the oncolytic virus. Also disclosed are methods of treating cancer comprising administering an oncolytic virus and measuring the level of Th1/Th2 biomarkers at two different time points to determine the patients response to the treatment. Also disclosed is a method for treating cancer in a patient comprising the administration of Th1 cytokine, an oncolytic virus and an agent which suppresses regulatory T cells and/or stimulates a cell mediated immune response.
Patent NZ-737380-A (NZ)
Title: Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Inventor: SONI PARESH
IPC: A61P9/10
Filed: 2013-06-28
Abstract: Use of eicosapentaenoic acid and docosahexaenoic acid in the manufacture of a medicament for reducing a risk of cardiovascular death, coronary revascularization, stroke, myocardial infarction, and/or unstable angina in a subject on statin therapy, wherein: (a) the subject has previously been identified as being on statin therapy and as having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL; and (b) the medicament is formulated for daily administration to provide about 1 g to about 4 g of the medicament per day for a period of at least about 2 years, and wherein the docosahexaenoic acid is in an amount up to about 10% by weight of the total fatty acids in the medicament.
Patent NZ-767645-A (NZ)
Title: Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods
Inventor: ROUSE THOMAS M
IPC: A61M31/00
Filed: 2019-03-14
Abstract: Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods are provided. In one embodiment, a substance dispensing apparatus includes a housing sized and shaped for handheld use, the housing having at least one wall and a biometric sensor coupled to the at least one wall; a processor in communication with the biometric sensor, the processor configured to determine whether an intended user’s unique biometric attribute is detected by the biometric sensor based on input received from the biometric sensor; and a pump in communication with the processor, the pump configured to dispense a substance from a reservoir to a mouth of the intended user in response to the processor determining that the intended user’s unique biometric attribute is detected by the biometric sensor.
Patent PT-105495-A (PT)
Title: Receptor no domínio da frequência para modulações sc-fde com stbc
Inventor: SILVA MARIO MARQUES DA
IPC: H04B1/06
Filed: 2011-01-20
Abstract: SÃO APRESENTADOS MÉTODOS PARA SUPORTAR TRANSMISSÕES BASEADAS NA TÉCNICA DE TRANSMISSÃO COM PORTADORA ÚNICA, COM IGUALAÇÃO NO DOMÍNIO DA FREQUÊNCIA (SC-FDE), UTILIZANDO DIVERSIDADE DE TRANSMISSÃO, COM CODIFICAÇÃO NO ESPAÇO E NO TEMPO (STBC). O OBJECTIVO DO SISTEMA PROPOSTO CONSISTE EM PERMITIR A DIFUSÃO DE INFORMAÇÃO A PARTIR DE TERMINAIS, CONSEGUINDO-SE UMA MELHOR EFICIÊNCIA DE DESEMPENHO E/OU DE POTÊNCIA.NESTA PATENTE É PROPOSTO UM RECEPTOR ITERATIVO DENOMINADO BLOCO ITERATIVO ¿ IGUALAÇÃO COM DECISÃO REALIMENTADA (IB-DFE) PARA O ESQUEMA DE DIVERSIDADE DE TRANSMISSÃO STBC, APLICÁVEL À TÉCNICA DE TRANSMISSÃO SC-FDE, USANDO DUAS (STBC2) OU QUATRO (STBC4) ANTENAS DE TRANSMISSÃO.O ESQUEMA DE TRANSMISSÃO PROPOSTO PODE SER IMPLEMENTADO COMO FAZENDO PARTE DE UM SISTEMA DE COMUNICAÇÕES INDEPENDENTE DIRECCIONADO PARA DIFUSÃO DE INFORMAÇÃO, COMO TAMBÉM PODE SER IMPLEMENTADO COMO UMA ADIÇÃO A UM SISTEMA DE COMUNICAÇÕES MÓVEIS JÁ EXISTENTE.